bile duct cancer cholangiocarcinoma
Conditions
Interventions
None listed
Sponsors
Stichting Leveronderzoek
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Adult cholangiocarcinoma (CCA) patients that will undergo surgery for this disease.
Exclusion criteria
Exclusion criteria: Patients who refuse blood donation/participation in the study Patients with a severe immunocompromised condition, or patients taking immunosuppressive medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameters are: 1) Frequencies and absolute cell counts of different lymphocyte populations that together compose the tumor-infiltrating lymphocyte pool. 2) Expression of co-stimulatory/co-inhibitory molecules on TIL vs lymphocytes isolated from tumor-free liver tissue vs circulating lymphocytes 3) Effect of blocking co-inhibitory molecules or stimulating co-stimulatory molecules expressed by TIL on their function (proliferation and cytokine production) in ex vivo co-culture experiments | — |
Secondary
| Measure | Time frame |
|---|---|
| Depending on the co-inhibitory molecules detected on TIL, immunohistochemistry will be performed on residual formalin-fixed paraffin-embedded tumor tissue that is regularly stored to identify the expression of the ligands of these co-inhibitory molecules (for instance PDL1+2 and GAL9) on tumor (infiltrating) cells. | — |
Countries
Netherlands
Outcome results
None listed